Inhibition of hepatitis C virus in mouse models by lipidoid nanoparticle-mediated systemic delivery of siRNA against PRK2.

MLA

Moon, Jae-Su, et al. “Inhibition of Hepatitis C Virus in Mouse Models by Lipidoid Nanoparticle-Mediated Systemic Delivery of SiRNA against PRK2.” Nanomedicine : Nanotechnology, Biology, and Medicine, vol. 12, no. 6, Aug. 2016, pp. 1489–98. EBSCOhost, https://doi.org/10.1016/j.nano.2016.02.015.

APA

Moon, J.-S., Lee, S.-H., Han, S.-H., Kim, E.-J., Cho, H., Lee, W., Kim, M.-K., Kim, T.-E., Park, H.-J., Rhee, J.-K., Kim, S.-J., Cho, S.-W., Han, S. H., & Oh, J.-W. (2016). Inhibition of hepatitis C virus in mouse models by lipidoid nanoparticle-mediated systemic delivery of siRNA against PRK2. Nanomedicine : Nanotechnology, Biology, and Medicine, 12(6), 1489–1498. https://doi.org/10.1016/j.nano.2016.02.015

Chicago

Moon, Jae-Su, Seung-Hoon Lee, Song-Hee Han, Eun-Jung Kim, Hee Cho, Wooseong Lee, Mi-Kyung Kim, et al. 2016. “Inhibition of Hepatitis C Virus in Mouse Models by Lipidoid Nanoparticle-Mediated Systemic Delivery of SiRNA against PRK2.” Nanomedicine : Nanotechnology, Biology, and Medicine 12 (6): 1489–98. doi:10.1016/j.nano.2016.02.015.